成都糖足哪个医院比较好治疗老烂腿到成都哪家医院?,成都静脉血栓治疗,成都治疗血管瘤什么医院好,成都血管瘤医院哪家好,成都静脉曲张医院哪家比较好,成都婴儿血管瘤哪里好治,成都检查静脉曲张的价格

TAIYUAN, June 18 (Xinhua) -- A Chinese medical university will join hands with the Massey University of New Zealand to set up a community clinic specializing in chronic diseases in north China's Shanxi Province.The community clinic in Taiyuan, the provincial capital city, will provide medical services to more than 7,500 residents in the city's Hanxiguandong community, Ma Qianjin, vice president of the Shanxi University of Traditional Chinese Medicine, said on Friday.Residents will be able to seek advice from both Chinese and New Zealand experts on how to prevent chronic diseases like diabetes, said Ma.The clinic, which is expected to open this year, will also provide residents with free health check-ups and create health records for them.Bruce Ullrich, a Massey University board member, said on Friday that the clinic will integrate Western service with traditional Chinese medical techniques in its prevention and treatment of chronic diseases."The community clinic will mainly focus on people with obesity, diabetes and other chronic diseases. The cost of disease prevention will be dramatically lower than the cost of treatment," said Ullrich.Zhang Xinwei, deputy director of the provincial science and technology bureau, said that if the clinic's practices are successful, the model may be adopted by other regions in China.

BEIJING, July 26 (Xinhuanet) -- Some forms of medical research involving animals containing human material should be more tightly regulated, a report warned.The warning was issued on Friday by an expert working group from the Academy of Medical Sciences in Britain.The report suggested the ban of the use of animal cells that can produce human sperm or egg cells. "We don't want scientists to cause problems for the future by overstepping the mark of what is publicly acceptable," said Professor Robin Lovell-Badge, a member of the expert working group.The controversy partly originated from a medical research in Britain. Three years ago, the researchers produced human embryos with the nucleus hollowed cow eggs, according to the Associated Press."This is a complex research area and there should be an ongoing dialogue between scientists, regulators and the wider public to address emerging issues." said Martin Bobrow, a professor of medical genetics at the University of Cambridge.

SINGAPORE, June 14 (Xinhua) -- Researchers from Singapore and China are conducting a research aimed at using different technologies to completely capture and convert carbon dioxide in industrial emissions into energy, local daily Lianhe Zaobao reported on Tuesday.The project, supported by the National Research Foundation (NSF) of Singapore, will make use of sunlight as well as photochemical and photosynthetic processes, the foundation said.The researchers involved in the five-year project are from China's Peking University and Singapore's National University of Singapore and the Nanyang Technological University. A research center will be established under the Campus for Research Excellence and Tehnological Enterprise, a program also known as CREATE, the foundation said.It will be the first project involving cooperation with a Chinese university under the program. It will be located at the University Town of the National University of Singapore due to be completed by the end of the year.Lee Yuan-Kun, a researcher at the National University of Singapore, said no single chemical process can capture and convert the carbon dioxide completely so the researchers will be first treating the emissions with photochemical and electrochemical processes to convert most of the carbon dioxide into energy resources such as methane.The gas with thinner carbon dioxide will then be used to grow microalgae, he said.Nevertheless, for the cost of renewable energy to be close to that of fossil fuel, the efficiency will have to be drastically improved by about five to 10 times, Lee said.The project is one of three energy research projects to be housed under the Campus for Research Excellence and Tehnological Enterprise program.Zhang Dongxiao, from the College of Engineering at Peking University, said that the research program seeks to develop energy efficient and environmentally friendly carbon capture technologies that can be applied in the manufacturing and chemical industries, and that it complements Peking University's strong capability in carbon storage."Reducing carbon intensity will not only benefit both countries in terms of cost competitiveness of products made, but also portrays a good image on our national responsibility to achieve a sustainable Earth," Zhang said. 

WASHINGTON, Sept. 12 (Xinhua) -- An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, U.S. researchers find.Over the course of four weeks, mice genetically engineered to lack the gene for protein kinase C (PKC) epsilon consumed less of a nicotine-containing water solution than normal mice, and were less likely to return to a chamber in which they had been given nicotine. In contrast, normal mice steadily increased their consumption of nicotine solution while the mice lacking PKC epsilon did not.The study conducted by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco, appeared Monday in the online edition of the Proceedings of the National Academy of Sciences.In normal mice, as in humans, nicotine binds to a certain class of nicotinic receptors located on dopamine neurons, which causes dopamine to be released in the brain. Dopamine creates a feeling of enjoyment, and thus prompts a sense of reward. Researchers found that mice lacking PKC epsilon are deficient in these nicotinic receptors.The finding complements earlier research in which researchers found that mice genetically engineered to lack the PKC epsilon enzyme drank less alcohol than normal mice and were disinclined to return to a chamber in which they had been given alcohol."This could mean that these mice might not get the same sense of reward from nicotine or alcohol," said Gallo senior associate director and investigator Robert Messing. "The enzyme looks like it regulates the part of the reward system that involves these nicotinic receptors."The reward system is a complex of areas in the brain that affect craving for nicotine, alcohol and other addictive substances.The next step in the research, said Messing, would be to develop compounds that inhibit PKC epsilon. The ultimate goal, he added, would be medications that could be used "to take the edge off of addiction by helping people get over some of their reward craving."